Rheumatoid Arthritis Journal Articles

• Safety of IV Golimumab in RA, PsA, and AS A pooled analysis of data from three trials provides insight into the safety profile of IV golimumab for the treatment of these rheumatologic conditions.
  Arthritis Research & Therapy, May 18, 2022
• Drug Dosing in Hospitalized Obese Patients With COVID-19 When making dosing decisions for the treatment of hospitalized COVID-19 patients with obesity, weight and BMI should be considered.
  Critical Care, May 11, 2022
• Manual Therapy in the Treatment of Cervicogenic Headache This study identified various manual therapy methods and techniques that are being evaluated for the treatment of cervicogenic headache. Which have shown the greatest efficacy?
  Headache, May 06, 2022
• Exercise Prescription for Osteoporosis: Back to Basics This article discusses the potential financial and health benefits of a supervised exercise therapy program for osteoporosis.
  Exercise and Sport Sciences Reviews, April 20, 2022
• Third mRNA Vaccine in Preventing COVID-19 Hospitalization According to this CDC report, a third dose of an mRNA COVID-19 vaccine significantly increases effectiveness against hospitalization among adults without and with immunocompromising conditions.
  Morbidity & Mortality Weekly Report, April 18, 2022
• Is Q-CT the Gold Standard for Detecting Spinal Osteoporosis? Dual-energy X-ray absorptiometry is currently considered as the gold standard for the evaluation of spinal osteoporosis, but could Q-CT provide a better alternative?
  Spine, April 06, 2022
• Immunogenicity 6 Months After BNT162b2 Vaccination in LTCFs This study shows that older adults in long-term care facilities experience a rapid loss of antibodies over the first 6 months after the second dose of BNT162b2 vaccine.
  Journal of the American Geriatrics Society, March 29, 2022
• Janus Kinase and Tyrosine Kinase Inhibitors in Dermatology This review details the mechanism of action of JAK inhibitors and assesses their efficacy and safety in the treatment of a wide variety of dermatological conditions.
  Skin Therapy Letter, March 17, 2022
• Rheumatic Disease Flare-Up After SARS-CoV-2 mRNA Vaccine A new study finds a low incidence of disease flare-up after mRNA SARS-CoV-2 vaccines among rheumatic musculoskeletal disease patients.
  Arthritis Research & Therapy, March 16, 2022
• The Epidemiology of Alopecia Areata This study elucidates the epidemiology of alopecia areata, focusing on incidence, demographics and patterns of healthcare utilization.
  The British Journal of Dermatology, March 14, 2022
• CV and VTE Risk Associated With JK Inhibitors in RA Janus kinase inhibitors are effective for the treatment of rheumatoid arthritis, but might they increase the risk of cardiovascular and venous thromboembolic events?
  Journal of Clinical Rheumatology, March 11, 2022
• Update on ERAS Pathways for Hip and Knee Arthroplasty Get up-to-date on the most current ERAS pathways and guidelines for total hip and knee arthroplasty.
  Current Orthopaedic Practice, March 10, 2022
• Prioritizing Referrals of Individuals At-Risk of RA When should patients with suspected inflammatory arthritis be referred to a rheumatologist? This article provides some guidance.
  Arthritis Research & Therapy, March 09, 2022
• Association Between Atopic Dermatitis and Hypertension This meta-analysis investigated whether persons with atopic dermatitis are at increased risk for hypertenstion.
  The British Journal of Dermatology, March 07, 2022
• Safety of Recombinant Zoster Vaccine in Rheumatology Patients Is the recombinant zoster vaccine safe to use in rheumatology patients taking immunosuppressive medications?
  Southern Medical Journal, February 23, 2022
• Psoriasis-related Treatment, Hospitalization Due to COVID-19 Have systemic treatments for psoriasis been associated with an increased risk of hospitalization or in-hospital mortality due to COVID-19?
  The British Journal of Dermatology, February 07, 2022
• Mindfulness-based Stress Reduction, CT, and BT for Chronic Pain This study compared cognitive therapy, mindfulness-based stress reduction, and behavior therapy in people with chronic low back pain. Did any one technique show superiority over the others?
  Pain, February 07, 2022
• Risk of VTE Associated With Tofacitinib in Patients With RA Does tofacitinib treatment increase the risk for venous thromboembolism in patients with rheumatoid arthritis?
  Rheumatology, February 02, 2022
• A Weight and Pain Management Program for RA With Obesity A newly developed behavioral intervention may help promote weight loss and pain self-management among rheumatoid arthritis patients with obesity.
  Journal of Clinical Rheumatology, January 19, 2022
• Pyoderma Gangrenosum Following Breast Reconstruction A patient postoperatively developed pyoderma gangrenosum after undergoing mastectomy with deep inferior epigastric perforator flap breast reconstruction. How was this complication managed?
  Wounds, January 14, 2022